North America Diagnostic Analytics in Healthcare Industry Market Size, Share & Trends Analysis Report By Deployment Mode, By Data Source, By End-User, By Type, By Technology, By Application, By Country and Growth Forecast, 2024 - 2031

North America Diagnostic Analytics in Healthcare Industry Market Size, Share & Trends Analysis Report By Deployment Mode, By Data Source, By End-User, By Type, By Technology, By Application, By Country and Growth Forecast, 2024 - 2031


The North America Diagnostic Analytics In Healthcare Industry Market would witness market growth of 28.2% CAGR during the forecast period (2024-2031).

The US market dominated the North America Diagnostic Analytics in Healthcare Industry Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $16,278.6 million by 2031. The Canada market is experiencing a CAGR of 30.9% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 29.8% during (2024 - 2031).

Diagnostic analytics has emerged as a transformative force in the healthcare industry, revolutionizing how diseases are detected, monitored, and managed. This data-driven methodology utilizes sophisticated tools and technologies to analyze intricate medical data, yielding actionable insights that substantially improve the efficiency and efficacy of healthcare delivery.

At its core, diagnostic analytics involves systematically analyzing diverse healthcare data, ranging from electronic health records (EHRs) and medical imaging to genomic and wearable device data. This capability has shifted the paradigm from reactive to proactive healthcare. Previously, diagnoses often relied on symptomatic presentations, which sometimes led to delayed interventions or suboptimal treatments.

Driven by rising healthcare spending and a developing private healthcare sector, Mexico is becoming a major player in the North American diagnostic analytics industry. The rising disease burden in Mexico underscores the urgent need for advanced healthcare solutions. Nearly 12.8 million Mexicans were diagnosed with diabetes in 2019, and this number is projected to escalate to 22.3 million by 2045, according to the National Library of Medicine. This alarming trend emphasizes the importance of digital tools, such as diagnostic analytics platforms and lifestyle disease management applications, in aiding patients and healthcare providers in monitoring and managing diabetes and related conditions effectively. Thus, the market across North America is marked by innovation and strong government support.

Based on Deployment Mode, the market is segmented into Cloud-Based, On-Premise, and Hybrid. Based on Data Source, the market is segmented into Clinical Data, Medical Imaging Data, Wearables & IoT Data, Lab Test Data, and Genomic Data. Based on End-User, the market is segmented into Hospitals, Diagnostic Laboratories, Clinics and Physician Practices, Research & Academic Institutes, and Insurance Companies & Other. Based on Type, the market is segmented into Predictive Analytics, Prescriptive Analytics, Descriptive Analytics, and Diagnostic Analytics. Based on Technology, the market is segmented into Artificial Intelligence (AI) & Machine Learning (ML), Big Data Analytics, Cloud-Based Analytics, Natural Language Processing (NLP)s, and Other Technology. Based on Application, the market is segmented into Disease Detection & Diagnosis, Clinical Decision Support, Personalized Treatment, Radiology & Medical Imaging, Patient Monitoring and Remote Diagnostics, and Other Application. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • Siemens Healthineers AG (Siemens AG)
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Qiagen N.V
  • Medtronic PLC
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Quest Diagnostics Incorporated
  • GE HealthCare Technologies, Inc.
North America Diagnostic Analytics In Healthcare Industry Market Report Segmentation

By Deployment Mode
  • Cloud-Based
  • On-Premise
  • Hybrid
By Data Source
  • Clinical Data
  • Medical Imaging Data
  • Wearables & IoT Data
  • Lab Test Data
  • Genomic Data
By End-User
  • Hospitals
  • Diagnostic Laboratories
  • Clinics and Physician Practices
  • Research & Academic Institutes
  • Insurance Companies & Other
By Type
  • Predictive Analytics
  • Prescriptive Analytics
  • Descriptive Analytics
  • Diagnostic Analytics
By Technology
  • Artificial Intelligence (AI) & Machine Learning (ML)
  • Big Data Analytics
  • Cloud-Based Analytics
  • Natural Language Processing (NLP)s
  • Other Technology
By Application
  • Disease Detection & Diagnosis
  • Clinical Decision Support
  • Personalized Treatment
  • Radiology & Medical Imaging
  • Patient Monitoring and Remote Diagnostics
  • Other Application
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Diagnostic Analytics in Healthcare Industry Market, by Deployment Mode
1.4.2 North America Diagnostic Analytics in Healthcare Industry Market, by Data Source
1.4.3 North America Diagnostic Analytics in Healthcare Industry Market, by End-User
1.4.4 North America Diagnostic Analytics in Healthcare Industry Market, by Type
1.4.5 North America Diagnostic Analytics in Healthcare Industry Market, by Technology
1.4.6 North America Diagnostic Analytics in Healthcare Industry Market, by Application
1.4.7 North America Diagnostic Analytics in Healthcare Industry Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Dec – 2024, Jun) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. North America Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
5.1 North America Cloud-Based Market by Country
5.2 North America On-Premise Market by Country
5.3 North America Hybrid Market by Country
Chapter 6. North America Diagnostic Analytics in Healthcare Industry Market by Data Source
6.1 North America Clinical Data Market by Region
6.2 North America Medical Imaging Data Market by Region
6.3 North America Wearables & IoT Data Market by Region
6.4 North America Lab Test Data Market by Region
6.5 North America Genomic Data Market by Region
Chapter 7. North America Diagnostic Analytics in Healthcare Industry Market by End-User
7.1 North America Hospitals Market by Country
7.2 North America Diagnostic Laboratories Market by Country
7.3 North America Clinics and Physician Practices Market by Country
7.4 North America Research & Academic Institutes Market by Country
7.5 North America Insurance Companies & Other Market by Country
Chapter 8. North America Diagnostic Analytics in Healthcare Industry Market by Type
8.1 North America Predictive Analytics Market by Country
8.2 North America Prescriptive Analytics Market by Country
8.3 North America Descriptive Analytics Market by Country
8.4 North America Diagnostic Analytics Market by Country
Chapter 9. North America Diagnostic Analytics in Healthcare Industry Market by Technology
9.1 North America Artificial Intelligence (AI) & Machine Learning (ML) Market by Country
9.2 North America Big Data Analytics Market by Country
9.3 North America Cloud-Based Analytics Market by Country
9.4 North America Natural Language Processing (NLP)s Market by Country
9.5 North America Other Technology Market by Country
Chapter 10. North America Diagnostic Analytics in Healthcare Industry Market by Application
10.1 North America Disease Detection & Diagnosis Market by Country
10.2 North America Clinical Decision Support Market by Country
10.3 North America Personalized Treatment Market by Country
10.4 North America Radiology & Medical Imaging Market by Country
10.5 North America Patient Monitoring and Remote Diagnostics Market by Country
10.6 North America Other Application Market by Country
Chapter 11. North America Diagnostic Analytics in Healthcare Industry Market by Country
11.1 US Diagnostic Analytics in Healthcare Industry Market
11.1.1 US Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
11.1.2 US Diagnostic Analytics in Healthcare Industry Market by Data Source
11.1.3 US Diagnostic Analytics in Healthcare Industry Market by End-User
11.1.4 US Diagnostic Analytics in Healthcare Industry Market by Type
11.1.5 US Diagnostic Analytics in Healthcare Industry Market by Technology
11.1.6 US Diagnostic Analytics in Healthcare Industry Market by Application
11.2 Canada Diagnostic Analytics in Healthcare Industry Market
11.2.1 Canada Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
11.2.2 Canada Diagnostic Analytics in Healthcare Industry Market by Data Source
11.2.3 Canada Diagnostic Analytics in Healthcare Industry Market by End-User
11.2.4 Canada Diagnostic Analytics in Healthcare Industry Market by Type
11.2.5 Canada Diagnostic Analytics in Healthcare Industry Market by Technology
11.2.6 Canada Diagnostic Analytics in Healthcare Industry Market by Application
11.3 Mexico Diagnostic Analytics in Healthcare Industry Market
11.3.1 Mexico Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
11.3.2 Mexico Diagnostic Analytics in Healthcare Industry Market by Data Source
11.3.3 Mexico Diagnostic Analytics in Healthcare Industry Market by End-User
11.3.4 Mexico Diagnostic Analytics in Healthcare Industry Market by Type
11.3.5 Mexico Diagnostic Analytics in Healthcare Industry Market by Technology
11.3.6 Mexico Diagnostic Analytics in Healthcare Industry Market by Application
11.4 Rest of North America Diagnostic Analytics in Healthcare Industry Market
11.4.1 Rest of North America Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
11.4.2 Rest of North America Diagnostic Analytics in Healthcare Industry Market by Data Source
11.4.3 Rest of North America Diagnostic Analytics in Healthcare Industry Market by End-User
11.4.4 Rest of North America Diagnostic Analytics in Healthcare Industry Market by Type
11.4.5 Rest of North America Diagnostic Analytics in Healthcare Industry Market by Technology
11.4.6 Rest of North America Diagnostic Analytics in Healthcare Industry Market by Application
Chapter 12. Company Profiles
12.1 Siemens Healthineers AG (Siemens AG)
12.1.1 Company Overview
12.1.2 Financial Analysis
12.1.3 Segmental and Regional Analysis
12.1.4 Research & Development Expense
12.1.5 Recent strategies and developments:
12.1.5.1 Partnerships, Collaborations, and Agreements:
12.1.5.2 Acquisition and Mergers:
12.1.6 SWOT Analysis
12.2 Abbott Laboratories
12.2.1 Company Overview
12.2.2 Financial Analysis
12.2.3 Segmental and Regional Analysis
12.2.4 Research & Development Expense
12.2.5 Recent strategies and developments:
12.2.5.1 Product Launches and Product Expansions:
12.2.5.2 Acquisition and Mergers:
12.2.6 SWOT Analysis
12.3 F. Hoffmann-La Roche Ltd.
12.3.1 Company Overview
12.3.2 Financial Analysis
12.3.3 Segmental and Regional Analysis
12.3.4 Research & Development Expense
12.3.5 Recent strategies and developments:
12.3.5.1 Partnerships, Collaborations, and Agreements:
12.3.5.2 Product Launches and Product Expansions:
12.3.5.3 Acquisition and Mergers:
12.3.6 SWOT Analysis
12.4 Danaher Corporation
12.4.1 Company Overview
12.4.2 Financial Analysis
12.4.3 Segmental and Regional Analysis
12.4.4 Research & Development Expense
12.4.5 Recent strategies and developments:
12.4.5.1 Partnerships, Collaborations, and Agreements:
12.4.5.2 Acquisition and Mergers:
12.4.6 SWOT Analysis
12.5 Qiagen N.V.
12.5.1 Company Overview
12.5.2 Financial Analysis
12.5.3 Regional Analysis
12.5.4 Research & Development Expenses
12.5.5 Recent strategies and developments:
12.5.5.1 Partnerships, Collaborations, and Agreements:
12.5.5.2 Acquisition and Mergers:
12.5.6 SWOT Analysis
12.6 Medtronic PLC
12.6.1 Company overview
12.6.2 Financial Analysis
12.6.3 Segmental and Regional Analysis
12.6.4 Research & Development Expenses
12.6.5 Recent strategies and developments:
12.6.5.1 Partnerships, Collaborations, and Agreements:
12.6.6 SWOT Analysis
12.7 Illumina, Inc.
12.7.1 Company Overview
12.7.2 Financial Analysis
12.7.3 Segment and Regional Analysis
12.7.4 Research & Development Expense
12.7.5 Recent strategies and developments:
12.7.5.1 Product Launches and Product Expansions:
12.7.5.2 Acquisition and Mergers:
12.7.6 SWOT Analysis
12.8 Thermo Fisher Scientific, Inc.
12.8.1 Company Overview
12.8.2 Financial Analysis
12.8.3 Segmental and Regional Analysis
12.8.4 Research & Development Expenses
12.8.5 Recent strategies and developments:
12.8.5.1 Partnerships, Collaborations, and Agreements:
12.8.5.2 Acquisition and Mergers:
12.8.6 SWOT Analysis
12.9 Quest Diagnostics Incorporated
12.9.1 Company Overview
12.9.2 Financial Analysis
12.9.3 Segmental Analysis
12.9.4 Recent strategies and developments:
12.9.4.1 Partnerships, Collaborations, and Agreements:
12.9.5 SWOT Analysis
12.10. GE HealthCare Technologies, Inc.
12.10.1 Company Overview
12.10.2 Financial Analysis
12.10.3 Segmental and Regional Analysis
12.10.4 Research & Development Expenses
12.10.5 Recent strategies and developments:
12.10.5.1 Partnerships, Collaborations, and Agreements:
12.10.5.2 Product Launches and Product Expansions:
12.10.6 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings